Feed IPHA
IP
Innate Pharma S.A.
IPHA · NASDAQ
$1.78 +0.00% (+$0.00)
1M -7.41%
Market Cap 146.0M €
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$158.28
8817.2% upside
Aktuální cena
$1.78
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
0 /100
Expensive P/S 52.40x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 63.58%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 0.00%
Op. margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor ROA 0.00%
Asset turnover 0.04x
ROIC 0.00%
Debt
59 /100
Moderate Int. coverage -110.77x
Net debt/EBITDA 0.13x
Current ratio 1.27x
Stability
26 /100
Unstable Rev. volatility 38.58%
EPS volatility 364.59%
Profitable years 0
Zeptejte se StockBota na IPHA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan E. Dickinson
Employees
163
Headquarters
Marseille
Nadcházející události
17 ZÁŘ
Earnings
Upcoming earnings report